Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Brivaracetam (10mg) Injection
Therapeutic Category
Antiepileptic, Neurology
Dosage Form
Injection
Packaging Type
Vial + W.F.I.
Packaging
10mg/ml
Price
₹199/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Bringcitam Injection is an effective antiepileptic medication used as an adjunctive therapy for managing partial-onset seizures. It works by binding to the synaptic vesicle protein 2A (SV2A) in the brain, stabilizing electrical activity and reducing seizure episodes. The injectable form ensures rapid action, making it particularly beneficial for patients unable to take oral medications or requiring immediate seizure control. Designed for precision, Bringcitam delivers reliable seizure management while minimizing disruptions to daily life. Its targeted mechanism of action and favorable safety profile make it a preferred choice in epilepsy care.
Common side effects may include dizziness, fatigue, somnolence, nausea, and injection site reactions.
Liv-Zymvigo is indicated for improving liver health, detoxification, aiding digestion, and supporting overall liver function.
Use only under medical supervision. Administer as per prescribed dosage. Avoid use in individuals with hypersensitivity to Brivaracetam or its components.
Store below 25°C in a cool, dry place, away from light and moisture. Keep out of reach of children.
Composition : Granisetron (1mg) Injection
Composition : Levetiracetam (100mg) Injection
Composition : Ondansetron (2mg)
Composition : Polymyxin B (500000IU) Injection
Composition : Ondansetron (2mg) + Ranitidine (25mg)
Composition : Meropenem (500mg) Injection
Composition : Vancomycin (1000mg) Injection
Composition : Meropenem (250mg)
Composition : Meropenem (1000mg) + Sulbactam (500mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Brivaracetam Injection has strong demand in the neurology and emergency hospital segment, making it a high-value product for medical distributors, wholesalers, and pharma franchise partners focusing on epilepsy and CNS injectable portfolios.
Medical distributors and agencies can benefit from consistent hospital demand for management of epilepsy, acute seizure episodes, and status epilepticus (in controlled settings). Brivaracetam is an antiepileptic drug that helps stabilize abnormal brain activity, strengthening a specialized CNS emergency-care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Brivaracetam Injection with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong hospital and neurology demand, emergency critical-care usage, ICU and neurology department prescriptions, institutional supply potential, reliable supply chain support, and good margins in CNS injectable medicines.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, territory rights, and distribution opportunities.